Submission and Eligibility
Abstract submission deadline: March 15, 2024
All submitted abstracts become the property of MDS.
All accepted abstracts are published by MDS.
An individual may be the first author on a maximum of three (3) abstracts.
An individual may be a contributing author on an unlimited number of abstracts.
MDS Members and non-members are welcome to submit abstracts.
There is no fee to submit an abstract.
*If your abstract includes a rating scale or other resources, please make sure permission has been granted and all applicable fees have been paid.
Abstract presenters are encouraged to attend the International Congress to present their abstract in person. In-person abstract presenters are required to register for the International Congress and pay applicable registration fees.
Abstracts must be submitted in their final form on March 15, 2024. Requests to edit abstract data and/or outcomes after the submission deadline will not be granted. All other abstract edits are not guaranteed.
The 2024 International Congress will take place in Philadelphia, PA, and will feature in-person printed poster presentations for all accepted abstracts.
- Accepted abstract presenters should plan to attend the Congress in full to present their printed poster during the scheduled poster session(s).
- Please plan to attend from September 27 – October 1, in case of any schedule changes
All accepted abstracts will be published in an e-supplement to the Movement Disorders journal online edition. All submitted abstracts become the property of MDS.
All accepted abstracts will be published on September 27, 2024, and available for viewing on the MDS Congress platform.
Accepted MDS abstracts are embargoed until 8:00 am EST (local Philadelphia time) on September 27, 2024.
Previously Published Abstracts & Plagiarism
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected.
Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.
Abstracts that have been previously published will not be accepted by MDS.
If the abstract submission is scheduled for publication after the submission deadline but prior to the MDS publication date, September 27, 2024, then the abstract must be withdrawn.
MDS does not accept abstracts that have been previously published by MDS (encore abstracts).
If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and the abstract will be rejected.
All abstracts presented at a previous MDS International Congress or MDS Regional Congress (PAS Congress or AOPMC) have been published by MDS.
Edits to abstracts after submitting are highly discouraged.
If edits to a submitted abstract are required, login to the online submission portal, https://catalyst.omnipress.com, and edit as needed. Click “submit” when you are finished. All edits must be submitted by the abstract submission deadline, March 15, 2024.
December 15 – March 15, 2024
You may edit a submitted abstract while submission is still open (before March 15, 2024).
March 16 – July 1, 2024
Requests to edit a submitted abstract after the submission deadline (March 15, 2024) must be received in writing by July 1, 2024, to firstname.lastname@example.org and are not guaranteed. Requests to edit data and/or outcomes of a submitted abstract will not be granted.
July 1, 2024 – Onward
After July 1, 2024, your abstract cannot be edited or withdrawn and will remain a part of the 2024 MDS published abstracts. All submitted abstracts become the property of MDS.
Text limit of 2,500 characters (including spaces) for the body of the abstract. The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information or reference sections.
All abstract submissions must be written and presented in English.
Abstracts should be arranged as follows:
*You may submit a case report using the standard abstract format
When compiling your submission please note the following:
- Do not include any identifying information directly on the abstract.
- Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.
- Only nonproprietary (generic) drug names should be used and should be written without capitals.
- Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category.
- If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.
- The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.
Uploading Images (Tables/Graphs)
Please note there is a separate upload field for tables and graphs. All images, tables, graphs, etc., will appear at the end of the abstract text in the final publication. When referencing an uploaded image within the abstract, enter the appropriate ID tag, as shown here; - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.
To list references, enter the appropriate ID tag.  for your first reference,  for your second reference,  for your third reference, etc.
The MDS Congress Scientific Program Committee will review all abstracts in March of 2024. The Committee shall be directed to reject abstracts for the following reasons:
- Plagiarism detected
- Marketing detected
- Subject not related to the field of Movement Disorders
- Does not meet basic requirements
All submitted abstracts will undergo plagiarism review through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
If it is determined by the Congress Scientific Program Committee that a submitted abstract is not entered in the optimal abstract category listing, MDS reserves the right to re-categorize the abstract on behalf of the author(s) without prior notification. The new category placement will be confirmed in the official abstract notification letter. If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.
Notification & Correspondence
All abstract notification e-mail and correspondence will be communicated to the designated contact person of the abstract; identified as ‘Contact for Official Abstract Correspondence’ on the official submission form. Abstract acceptance notifications will be sent to the designated contact person via e-mail in May 2024.
All submitted abstracts will receive a confirmation e-mail to the designated contact person.
If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site, https://catalyst.omnipress.com, to verify the status of the submission.
After abstract notifications have been sent via e-mail, an official abstract notification letter will be available through the submission site and can be downloaded and printed at any time.
All confirmed abstract submissions will be reviewed for acceptance by MDS.
Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS.
Please ensure that email@example.com and firstname.lastname@example.org are designated as a “safe senders” to ensure timely correspondence regarding the abstract submission.
Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will be sent from email@example.com. Abstract status can also be checked directly on the submission site in May 2024.
Withdrawing a Submitted Abstract
December 15 – March 15, 2024
You may withdraw a submitted abstract at any time while submission is still open (before March 15, 2024). To withdraw an abstract, login to your submission and click on 'Withdraw'. There is no penalty to withdraw your abstract.
March 16 – July 1, 2024
Requests to withdraw a submitted abstract after the submission deadline (March 15, 2024) must be received in writing by July 1, 2024, to firstname.lastname@example.org.
July 1, 2024 – Onward
After July 1, 2024, your abstract cannot be withdrawn and will remain a part of the 2024 MDS published abstracts. All submitted abstracts become the property of MDS.